Premium
E-pharmacy major PharmEasy has appointed investment bank Avendus Capital to tap external capital, even as its existing investors are planning a fund infusion to bolster the company’s equity, three people with knowledge of the development said. Existing investors, largely led by Prosus Ventures (Formerly Naspers Ventures), Temasek Holdings, CDPQ and TPG ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
